U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Biologic License Application (BLA): 761116
Company: STEMLINE THERAPEUTICS INC
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
ELZONRIS TAGRAXOFUSP-ERZS 1000MCG SOLUTION;INJECTION Prescription None No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
12/21/2018 ORIG-1 Approval N/A; Orphan Label (PDF)
Review
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761116s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2018/761116Orig1s000TOC.cfm
Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
07/26/2023 SUPPL-9 Supplement Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761116s009lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/761116Orig1s009ltr.pdf
11/03/2022 SUPPL-7 Supplement Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761116s007lbledt.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/761116Orig1s007ltr.pdf
10/27/2022 SUPPL-5 Supplement Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761116s005lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/761116Orig1s005ltr.pdf
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
07/26/2023 SUPPL-9 Labeling-Container/Carton Labels Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761116s009lbl.pdf
07/26/2023 SUPPL-9 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761116s009lbl.pdf
11/03/2022 SUPPL-7 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761116s007lbledt.pdf
10/27/2022 SUPPL-5 Efficacy-Labeling Change With Clinical Data Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761116s005lbl.pdf
12/21/2018 ORIG-1 Approval Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761116s000lbl.pdf
Back to Top